Health Care
Commentary
The Big Beautiful Bill Fixes One Drug Problem—But Highlights An Even Bigger One
Buried within the One Big Beautiful Bill Act, which President Donald Trump signed into law July 4, is a provision that could improve or even save the lives of the 30 million Americans suffering from rare diseases. That provision is the Orphan Cures Act, which exempts certain drugs that treat ...
Sally C. Pipes
July 21, 2025
Commentary
One Big Beautiful Bill: A Fiscal Lifeline for Medicaid, Taxpayers
The “One Big Beautiful Bill” Act (OBBBA) signed into law by President Donald Trump on July 4 is set to help pull America’s healthcare system back from the brink of fiscal disaster. Read the entire op-ed here.
Sally C. Pipes
July 16, 2025
Blog
Read part 1 of a 3 part series on drug pricing
Conspiracies Aside, Drug Company Profits Are Average
Recently, the Federal Trade Commission (FTC) held its first of three listening sessions on the pharmaceutical market. The goal was to discuss reforms that will improve drug affordability by increasing “generic and biosimilar availability” and promoting “competition”. Achieving these goals is essential. The flaw of the first listening session is ...
Wayne Winegarden
July 16, 2025
Commentary
The Culprit Impeding Drug Competition Is Not Who The Feds Expected
The Federal Trade Commission and U.S. Department of Justice recently kicked off a series of listening sessions to examine barriers to competition in the drug industry. The title of the first session—”Anticompetitive Conduct by Pharmaceutical Companies”—made it seem that regulators would chiefly investigate biotech firms. Yet by the end, panelists ...
Sally C. Pipes
July 14, 2025
Commentary
No, Donald Trump didn’t just slash Medicaid
Republicans’ One Big Beautiful Bill Act is now law. Democrats have wasted no time accusing the GOP of enshrining devastating “cuts” to Medicaid, the joint federal-state entitlement that provides health coverage for low-income Americans. That’s rubbish. The measure takes steps to restrain Medicaid’s rampant growth in recent years so that ...
Sally C. Pipes
July 14, 2025
Commentary
Cheap Drugs from Canada Can’t Make America Healthy
The U.S. Food and Drug Administration just announced plans to help states and Indian tribes purchase certain prescription drugs from Canada, where brand-name medicines tend to be cheaper because the government caps their price. The new guidance is part of a larger Trump administration effort to cut drug prices for ...
Sally C. Pipes
July 11, 2025
Commentary
As PBMs Drive Up Drug Prices, Silence Is Not Golden
The Trump administration has been mum in recent weeks on its “most favored nation” drug pricing plan, which broadly aims to link U.S. prices for medicines to the lowest prices in other developed countries. It’s unclear what those prices will be, how they’ll be determined, or how the administration will ...
Sally C. Pipes
July 9, 2025
Commentary
A Promising New AIDS Drug Highlights The Dangers Of Price Controls
The U.S. Food and Drug Administration approved a shot last month that effectively prevents HIV. At-risk people simply need to receive the injection every six months. The new drug, called lenacapavir, comes almost exactly 44 years after the first case of AIDS was reported by what’s now known as the ...
Sally C. Pipes
July 7, 2025
Commentary
Let the Message Be Clear: Canadian Healthcare Failed
Meet Mary, a 60-year-old woman from British Columbia. She needed a colonoscopy to confirm her cancer diagnosis. Mary spent four months on a waiting list. Then her bowel ruptured, and she suffered life-threatening sepsis. Due to the delay in treating her cancer, she had to get chemotherapy, which came with ...
Sally C. Pipes
July 2, 2025
Commentary
Trump tackles waste, fraud, and abuse in Obamacare
The Trump administration earlier this month finalized a rule that aims to stop waste, fraud, and abuse in the federally subsidized Obamacare exchanges. It’s about time. Millions of people who don’t qualify for free health coverage are receiving it on the public’s dime. The new rule will restore some measure ...
Sally C. Pipes
June 30, 2025
The Big Beautiful Bill Fixes One Drug Problem—But Highlights An Even Bigger One
Buried within the One Big Beautiful Bill Act, which President Donald Trump signed into law July 4, is a provision that could improve or even save the lives of the 30 million Americans suffering from rare diseases. That provision is the Orphan Cures Act, which exempts certain drugs that treat ...
One Big Beautiful Bill: A Fiscal Lifeline for Medicaid, Taxpayers
The “One Big Beautiful Bill” Act (OBBBA) signed into law by President Donald Trump on July 4 is set to help pull America’s healthcare system back from the brink of fiscal disaster. Read the entire op-ed here.
Read part 1 of a 3 part series on drug pricing
Conspiracies Aside, Drug Company Profits Are Average
Recently, the Federal Trade Commission (FTC) held its first of three listening sessions on the pharmaceutical market. The goal was to discuss reforms that will improve drug affordability by increasing “generic and biosimilar availability” and promoting “competition”. Achieving these goals is essential. The flaw of the first listening session is ...
The Culprit Impeding Drug Competition Is Not Who The Feds Expected
The Federal Trade Commission and U.S. Department of Justice recently kicked off a series of listening sessions to examine barriers to competition in the drug industry. The title of the first session—”Anticompetitive Conduct by Pharmaceutical Companies”—made it seem that regulators would chiefly investigate biotech firms. Yet by the end, panelists ...
No, Donald Trump didn’t just slash Medicaid
Republicans’ One Big Beautiful Bill Act is now law. Democrats have wasted no time accusing the GOP of enshrining devastating “cuts” to Medicaid, the joint federal-state entitlement that provides health coverage for low-income Americans. That’s rubbish. The measure takes steps to restrain Medicaid’s rampant growth in recent years so that ...
Cheap Drugs from Canada Can’t Make America Healthy
The U.S. Food and Drug Administration just announced plans to help states and Indian tribes purchase certain prescription drugs from Canada, where brand-name medicines tend to be cheaper because the government caps their price. The new guidance is part of a larger Trump administration effort to cut drug prices for ...
As PBMs Drive Up Drug Prices, Silence Is Not Golden
The Trump administration has been mum in recent weeks on its “most favored nation” drug pricing plan, which broadly aims to link U.S. prices for medicines to the lowest prices in other developed countries. It’s unclear what those prices will be, how they’ll be determined, or how the administration will ...
A Promising New AIDS Drug Highlights The Dangers Of Price Controls
The U.S. Food and Drug Administration approved a shot last month that effectively prevents HIV. At-risk people simply need to receive the injection every six months. The new drug, called lenacapavir, comes almost exactly 44 years after the first case of AIDS was reported by what’s now known as the ...
Let the Message Be Clear: Canadian Healthcare Failed
Meet Mary, a 60-year-old woman from British Columbia. She needed a colonoscopy to confirm her cancer diagnosis. Mary spent four months on a waiting list. Then her bowel ruptured, and she suffered life-threatening sepsis. Due to the delay in treating her cancer, she had to get chemotherapy, which came with ...
Trump tackles waste, fraud, and abuse in Obamacare
The Trump administration earlier this month finalized a rule that aims to stop waste, fraud, and abuse in the federally subsidized Obamacare exchanges. It’s about time. Millions of people who don’t qualify for free health coverage are receiving it on the public’s dime. The new rule will restore some measure ...